Corteva Settles North Carolina PFAS Claims for $66M Share of $455M Deal
CTVA sits 40% above its 52-week low of $60.535.
Summary
Corteva settled North Carolina PFAS litigation with a $66M direct share of a $455M deal, plus a 29% guarantee of Chemours' payments and a $135M reserve fund backstop.
Key Events · Legal and Risk Events · CTVA
-
North Carolina PFAS Settlement
Corteva, DuPont, and Chemours agreed to pay $455M over 15 years to resolve statewide PFAS claims; Corteva's direct share is approximately $66M (14.5% of the total).
-
Chemours Payment Guarantee
Corteva and DuPont must guarantee Chemours' settlement share on a 29%/71% basis if Chemours defaults, adding contingent liability beyond Corteva's direct payment.
-
$135M Reserve Fund Backstop
Corteva and DuPont must establish a $135M reserve fund via line of credit, letter of credit, or surety bond to secure Chemours' remaining NC Consent Order obligations; Corteva's share is 29%.
-
MOU Cap Restructured
The settlement applies $210M NPV against the $4B MOU qualified spend cap using an 8% discount rate over 25 years, and future MOU escrow contributions are deemed satisfied.
Analysis · CTVA · Industrial Applications And Services
A comprehensive settlement with North Carolina resolves statewide PFAS claims tied to the Fayetteville Works site for Corteva, DuPont, and Chemours. Corteva's direct payment share is approximately $66 million over 15 years, but the larger exposure is the guarantee obligation: Corteva and DuPont must backstop Chemours' settlement payments on a 29%/71% basis and fund a $135 million reserve facility to secure Chemours' remaining obligations under the 2019 NC Consent Order. The settlement also restructures the MOU economics — applying a $210 million net present value against the $4 billion qualified spend cap and eliminating future escrow contributions. This removes a major multi-year litigation overhang while adding contingent financial obligations that could materialize if Chemours defaults.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.8% of the 1864 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTVA was trading at $84.75 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $56.5B. The 52-week trading range was $60.54 to $90.97. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.